Mangeng Cheng - Pharmacol, Merck & Co Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 85 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure 3 from CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers

Mangeng Cheng,Matthew R. Quail,Diane E. Gingrich,Gregory R. Ott,Lihui Lu, Weihua Wan,Mark S. Albom,Thelma S. Angeles,Lisa D. Aimone,Flavio Cristofani,Rodolfo Machiorlatti,Cristina Abele,Mark A. Ator,Bruce D. Dorsey,Giorgio Inghirami,Bruce A. Ruggeri

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 1, Figures 1-2 from CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers

openalex（2023）

Cited0Views0Bibtex

Discovery of a Novel Small Molecule Inhibitor of the YAP1/TAZ-TEAD Transcriptional Complex

Casey J. Moure,Christopher Sondey,Mangeng Cheng,My Mansueto,Rafael Fernandez,Sebastian E. Schneider, Julia V. Ramirez,Brian Long,Erin DiMauro, Brandon Vara,Charles Yeung, Abe Achab,Jongwon Lim,Ronald Kim,Cayetana Zarate, Jonathan Bennett,Rachel Palte,Robert Foti,Vladimir Simov,Evan Barry

CANCER RESEARCH（2022）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn